What would you say re:bisphosphonates and known bone lesion(s)? I am on ADT3, second round. Would you rx Zometa or start with fosomax? I am aware of the jaw necrosis side effect possibilty. My bone density has always been good, even with the first round of ADT3….lowest was a T score of +0.95, usually T=+ 1.2-1.4.

As the many side effects of Zometa have been revealed, I find myself using it less and less. Fosamax is much safer. However, of late I have become most impressed with low dose estrogen as a way to protect bone. I use Vivelle dot 0.025 mg/day patch. This often results in a significant increase in bone density and not just prevention of bone loss. Additionally, it lessens hot flashes and will often eliminate them altogether. Alterations in brain function seem also less of a problem when the patch is used.

Some physicians use Zometa because they think it aids in controlling bone. There is some evidence to support this contention, but it is not very strong. However, the one place where I still recommend Zometa is in men with very extensive bone disease and evidence of cancer that is unusually aggressive. Out of the close to 1,000 patients in our clinic, I would guess that fewer than 30 are on Zometa. In contrast, quite a few are on Fosamax or Actonel combined with Vivelle dot. However, most are on Vivelle dot alone.

Ask Dr. Espinosa

Geo Espinosa, N.D., L.Ac, CNS, RH (AHG) is the Director of the Integrative Urological Center at New York University Langone Medical Center. Before joining NYU, Dr. Espinosa was a clinician, researcher and director of clinical trials at the Center for Holistic Urology at Columbia University Medical Center. He is a licensed naturopathic doctor, licensed acupuncturist, a Certified Nutrition Specialist and a Registered Herbalist. Dr. Espinosa is an author of the naturopathic entry in 1000 Cures for 200 ailments, by Harper Collins; March 2007 and “Prostate cancer – Nutrients that may slow its progression,” Food and Nutrients in Disease Management - Maryland: Cadmus Publishing, 2009.

Ask Dr. Myers

Medical oncologist and prostate cancer survivor, Dr Charles "Snuffy" Myers was a key player in creating AZT, Suranim, and Phenylacetate while working at the National Institute of Health. With over 250 research papers published, Myers is one of the leading developers of today's prostate cancer canon on both the research and treatment side of the test tube. Former Cancer Director at the University of Virginia, Myers opened the American Institute for Diseases of the Prostate in 2002 to provide men with the kind of comprehensive care that saved his own life. Dr. Myers has long been popular among prostate cancer patients as a speaker because of his ability to explain science and medicine in easy-to-understand language.

Ask Dr. Latini

Dr. Latini welcomes your questions about the psycho-social dimensions of Prostate Cancer, particularly those presented by Gay and Bisexual men. Dr. Latini is an assistant professor of urology at Baylor College of Medicine. Before joining Baylor, he spent six years in the Department of Urology at the University of California, San Francisco. Dr. Latini is a clinical health psychologist whose work concentrates on cancer survivorship and symptom management for persons living with genitourinary cancer.